Health, hygiene and household care producer Reckitt Benckiser (RB) has posted growth and margin expansion in full year 2015, according to its recently disclosed financial reports.
RB’s total revenues rose to £8.874 billion ($12.684 billion), with organic growth up 6% on full year 2014. The company claims its gross margin increased by +140bps to 59.1% (totaling £5.246 billion / $7.498 billion), driven bymix, input costs, and cost programmes. Operating profit was up 4% to £2.241 billion ($3.203 billion) versus FY 2014.
Commenting on the results, RB chief executive officer Rakesh Kapoor said: “RB delivered excellent growth and margin expansion in 2015 as a result of our continued focus on our Health, Hygiene and Home Powerbrand portfolio and supported by our culture of innovation and agility”.
“Despite a year of mixed market conditions, we achieved broad-based growth (+6% LFL), across both developed and developing markets. This was led by an exceptional performance in Consumer Health, due to both a strong flu season at the beginning of the year and outstanding performances from our innovations on brands such as Scholl, Durex, Nurofen and Strepsils”.
Source: Reckitt Benckiser